Zachs also shows 2 BUY recommendation. Those reports are dated 10/4.
The one out today, 10/5, is from ValueEngine. It has $EARS as a strong sell based on it's proprietary ranking system which puts $EARS against other biotechs. In that system, biotechs with revenues are going to smash $EARS, and that's exactly why it's listed as a strong sell. Oddly, the report lists 1 STRONG BUY recommendation. Wish they showed the names of the firms.
Anyway, nice to see any coverage of $EARS at all. No one was covering for a long while.
Know What You Own. My posts should not be construed as investment advice.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM